Clinical Trials Directory

Trials / Completed

CompletedNCT06809738

Anatomical Scale for the Prognosis of Fournier Syndrome.

Proposal for an Anatomical Scale for the Prognosis of Fournier Syndrome.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
58 (actual)
Sponsor
Instituto Mexicano del Seguro Social · Other Government
Sex
Male
Age
40 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Type of study: Case series. Universe of study: Records of patients with Fournier syndrome treated using the 3-stage reconstructive technique assigned and treated at the Mexican Social Security Institute: Regional General Hospital No. 1 of Mérida, Yucatán, during the years 2021-2024. Population under study: Patients diagnosed with Fournier syndrome.

Detailed description

The first surgical stage consists of damage limitation and extension analysis. In the second surgical stage, it was necessary to wash and prepare the area to be remodeled with the joint creation of the testicular resting space delimited by the fascia of the adductor muscles of the proximal lower limb. Finally, in the third surgical stage, the wound is remodeled and addressed. The surgery was performed in patients with extensive involvement that could not be resolved with minor surgery. The 3-stage reconstructive technique can be summarized as follows: 1. Analysis and limitation of the tissue injury. Bilateral testicular and spermatic cord dissection. 2. Formation of cutaneous flaps and bilateral inguinal neocavity. 3. Perineal-scrotal reconstruction with fascial facing and cutaneous flaps

Conditions

Interventions

TypeNameDescription
PROCEDUREreconstructive technique1. Analysis and limitation of the tissue injury. Bilateral testicular and spermatic cord dissection. 2. Formation of cutaneous flaps and bilateral inguinal neocavity. 3. Perineal-scrotal reconstruction with fascial facing and cutaneous flaps

Timeline

Start date
2021-01-01
Primary completion
2024-12-30
Completion
2024-12-31
First posted
2025-02-05
Last updated
2025-02-05

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT06809738. Inclusion in this directory is not an endorsement.